Access papers supplied by Dr. Peoples to include Phase I GP2 Clinical Trial Results (2010) and Phase II GP2 Clinical Trial Results presented at the 2013 ASCO Annual Meeting.
Courtesy Professor Dr. John Delinassios
International Institute of Anticancer Research (IIAR)
Journals: Anticancer Research, In Vivo, Cancer Genomics & Proteomics
1st km Kapandritiou-Kalamou Rd, PO. Box 22, GR-19014, Kapandriti, Attiki, Greece
USA Branch: Anticancer Research USA, Inc., PO Box 280, Belmar, NJ 07719,
USA 229-505-2945 ext. 1 Fax:+30-22950-52945 ext. 2.E-mail:
Email: subscriptions@iiar-anticancer.org
Feel free to look at all the available articles of Anticancer Research
located at:** http://ar.iiarjournals.org/search
(Click on the link, type “vaccine” in the box: “Text, Abstract, Title”)
Cite the complete reference and Journal. The material is the property of
IIAR.
This article is property of the journal Anticancer Research: